Difficulty: Medium
Average Score: 74%
Testbank
A client is recently diagnosed with Crohn disease and is beginning treatment. What first-line treatment does the nurse expect that the client will be placed on to decrease the inflammatory response?
Correct answer
D
Rationale
Sulfasalazine is the first-line treatment expected for a client with Crohn disease to help decrease the inflammatory response.
Sulfasalazine is an anti-inflammatory medication specifically used to treat inflammatory bowel diseases like Crohn's disease by inhibiting the production of inflammatory mediators, thereby reducing symptoms and promoting remission.
A: Ciprofloxacin is an antibiotic that may be used to treat infections but does not address the underlying inflammatory process associated with Crohn disease.
B: Methotrexate is an immunosuppressant that can be used for Crohn disease but is typically considered in cases where first-line therapies fail, making it less suitable as an initial treatment.
C: Azathioprine is an immunosuppressive agent effective for Crohn disease management, but it is generally not the first choice due to its slower onset of action compared to sulfasalazine.
Sulfasalazine is an anti-inflammatory medication specifically used to treat inflammatory bowel diseases like Crohn's disease by inhibiting the production of inflammatory mediators, thereby reducing symptoms and promoting remission.
A: Ciprofloxacin is an antibiotic that may be used to treat infections but does not address the underlying inflammatory process associated with Crohn disease.
B: Methotrexate is an immunosuppressant that can be used for Crohn disease but is typically considered in cases where first-line therapies fail, making it less suitable as an initial treatment.
C: Azathioprine is an immunosuppressive agent effective for Crohn disease management, but it is generally not the first choice due to its slower onset of action compared to sulfasalazine.